🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Batefenterol is a novel bifunctional molecule that combines muscarinic anta...
Status
Completed
Location
GSK Investigational Site
Start Date
2015-11-06
Trial ID
NCT02570165
Treatments Being Tested
This study will evaluate the efficacy and safety data of AZD8871 in patient...
Status
Completed
Location
Research Site
Start Date
2018-10-10
Trial ID
NCT03645434
Treatments Being Tested
The primary objective is to compare the efficacy of UMEC/VI Inhalation Powd...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-09-15
Trial ID
NCT01899742
Treatments Being Tested
The purpose of this study is to evaluate the lung function response to UMEC...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-10
Trial ID
NCT01716520
Treatments Being Tested
The goal of this clinical trial is to determine if triple inhaled therapy w...
Status
Completed
Location
Narongkorn Saiphoklang
Start Date
2025-04-01
Trial ID
NCT06905483
Treatments Being Tested
This study is a 12-week, multicenter, randomized, double blind, parallel gr...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-09-01
Trial ID
NCT02152605
This study looks at data from people with chronic obstructive pulmonary dis...
Status
Completed
Location
eMax health
Start Date
2021-12-17
Trial ID
NCT05169424
The primary objective of this study is to assess the effect of umeclidinium...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-07-14
Trial ID
NCT02799784
Treatments Being Tested
Investigators are building an empirical evidence base for real world data t...
Status
Completed
Location
Brigham and Women's Hospital
Start Date
2020-12-13
Trial ID
NCT05062304
Treatments Being Tested
The study aims to evaluate the efficacy, safety and tolerability of FF/UMEC...
Status
Completed
Location
GSK Investigational Site
Start Date
2021-07-29
Trial ID
NCT04937387
Treatments Being Tested